Revolutionizing orthopaedic surgery through evidence-based dignostics
Our Mission
To equip surgeons with next-generation quantitative tools to enhance clinical outcomes in orthopaedic surgery
The Challenge
In joint surgery, surgeons are limited by current clinical approach for diagnosis of tissue pathology:
Subjective visual assessment
Unable to detect early-stage damage
Unreliable diagnosis
Our Solution
JEDl – a smart optical sensor that enables deep tissue and bone assessment in real-time beyond the surgeon’s visual reach
Accurate objective diagnosis
Early disease detection via assessment of molecular changes
Quantitative diagnostic scoring of tissue pathology (tissue quality index)
Our Product
Our flagship product (JEDI) is an easy-to-use probe that enables the surgeon to diagnosis tissue intergrity in real-time based on near-infrared spectroscopy and machine learning.
JEDI is an easy-to-use optical system that enables the surgeon to diagnosis tissue integrity in real-time based on near-infrared spectroscopy and machine learning.
Ergonomic
Design is similar to traditional arthroscopic hook for quick learning and easy adoption
Ergonomic
Design is similar to traditional arthroscopic hook for quick learning and easy adoption
Low latency
Real-time assessment with minimal extension of surgery time
Low latency
Real-time assessment with minimal extension of surgery time
Objective
Highly sensitive and specific assessment
Adjustable screen with a light
up screen edge indicator
The ergonomic JEDI probe
comes with a light indicator
Measurement is activated
through a foot pedal, ensuring
uncompromised hand
dexterity
Smart
Optical sensor combines photonics and AI for disease diagnosis
Stand-alone
No secondary device or attachment need
Stand-alone
No secondary device or attachment need
Multi-purpose
Assessment of cartilage, subchondral bone and meniscus during the same procedur
Multi-purpose
Assessment of cartilage, subchondral bone and meniscus during the same procedur
Easy to use
Smart and intuitive user interface for the OR
JEDI team at the Nordic Life Science Days 2024 at Malmö, Sweden
This publication shows the capability of near infrared spectroscopy, the base technology in JEDI, for estimating articular cartilage thickness. The study was conducted using animals samples but has now been validated in human joints.
The Biomedical Spectroscopy Lab wins Terkko Health X 2021 accelerator programme.
JEDI is a Research to Business project funded by Business Finland to commercialize the research innovation from the Biomedical Spectroscopy Lab, University of Eastern Finland, Kuopio, Finland. The project’s mission will be to develop solutions that will revolutionize orthopaedic surgery through evidence-based diagnostics by enabling rapid and non-destructive diagnosis of tissue pathology without compromising workflows. The ultimate goal is to develop novel technologies to support clinicians in delivering optimal to enable better patient outcomes. Upon completion of the project, the optimal commercialisation pathway for JEDI to support objective assessment of tissue integrity during joint surgery will be determined and implemented.
The team
Associate Professor, PhD
BIOMEDICAL ENGINEERING
Project PI and expert in biospectroscopy. Background in Electrical (BSc. Hons.) and Biomedical (PhD) Engineering, with specific focus on biomedical instrumentation
Docent, PhD
BIOPHOTONICS AND SPECTROSCOPY
Project manager and technology champion. Holds a PhD in optics, with expertise in design and development of optical instrumentation.
MSc
BUSINESS AND MARKETING
Business champion. Holds an MSc in industrial design and has more than a decade experience in MedTech startups.
MSc
BIOMECHANICS
MSc
COMPUTATIONAL MODELLING IN BIOPHOTONICS
PhD
MACHINE LEARNING
Research to Business Project Timeline
Eager to hear more about our endeavours? Get in touch by filling in the form below:
JEDI is a Research to Business project funded by Business Finland to commercialize the research innovation from the Biomedical Spectroscopy Lab, University of Eastern Finland, Kuopio, Finland. The project’s mission will be to develop solutions that will revolutionize orthopaedic surgery through evidence-based diagnostics by enabling rapid and non-destructive diagnosis of tissue pathology without compromising workflows.
The ultimate goal is to develop novel technologies to support clinicians in delivering optimal to enable better patient outcomes. Upon completion of the project, the optimal commercialisation pathway for JEDI to support objective assessment of tissue integrity during joint surgery will be determined and implemented.
